<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007747.ref013">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Robbiani</surname>
   <given-names>DF</given-names>
  </name>, 
  <name>
   <surname>Bozzacco</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Keeffe</surname>
   <given-names>JR</given-names>
  </name>, 
  <name>
   <surname>Khouri</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Olsen</surname>
   <given-names>PC</given-names>
  </name>, 
  <name>
   <surname>Gazumyan</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico</article-title>. 
  <source>Cell</source>. 
  <year>2017</year>;
  <volume>169</volume>(
  <issue>4</issue>):
  <fpage>597</fpage>â€“
  <lpage>609 e11</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.cell.2017.04.024</pub-id> .
  <?supplied-pmid 28475892?>
  <pub-id pub-id-type="pmid">28475892</pub-id>
 </mixed-citation>
</ref>
